Dr. Stephen Louis Rennyson, MD

Dr. Rennyson practices at The Sanger Clinic in Charlotte, North Carolina.

Dr. Rennyson's NPI, 1912035767, was assigned on March 2, 2007. Dr. Rennyson graduated from Eastern Virginia Medical School in 2006. Dr. Rennyson holds North Carolina license 2011-00651.

Dr. Rennyson's primary practice is The Sanger Clinic, at 10650 Park Rd, Charlotte, NC 28210 in Mecklenburg County. The practice phone is (704) 667-3840.

Dr. Rennyson's primary practice is The Sanger Clinic in Charlotte, North Carolina. Dr. Rennyson is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Rennyson to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rennyson practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rennyson's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rennyson is licensed in North Carolina.

CMS data shows 2,162 Medicare services from Dr. Rennyson across 29 procedure codes in 2024, for 1,203 Medicare patients. Medicare paid $119,331 for them.

CMS counts 1,203 Medicare patients who saw Dr. Rennyson in 2024. The largest group is 75 to 84, with 531 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rennyson's median patient age at 74, with 52% women.

In 2024, Dr. Rennyson wrote 1,668 Medicare Part D claims for 374 patients. 76% of them were for generic drugs. CMS names the drug for 1,528 of them, across 26 drugs with 11 or more claims each, at $361,020 in total drug cost. In 2023, CMS named 2,705 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Rennyson for performance year 2024, reported through an alternative payment model (APM). Dr. Rennyson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Rennyson. The most frequent topics are Heart-Assist Devices and Heart Failure. Dr. Rennyson has published most often in ASAIO J. Dr. Rennyson's most frequent co-authors are Vigneshwar Kasirajan, MD, Keyur Shah, MD and Rajiv Malhotra, DO, MS.

CMS Open Payments shows 230 general payments to Dr. Rennyson from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 85% of the total. Novartis Pharmaceuticals Corporation paid the most, $172,264. It also lists 1 research payment totaling $108 in 2024.

Dr. Rennyson graduated from Eastern Virginia Medical School in 2006.